Y-Intercept (HK)’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $212K | Sell |
12,676
-180,711
| -93% | -$3.03M | 0.01% | 1448 |
|
|
2025
Q1 | $2.97M | Buy |
193,387
+63,241
| +49% | +$972K | 0.2% | 115 |
|
|
2024
Q4 | $2.87M | Buy |
+130,146
| New | +$2.87M | 0.19% | 136 |
|
|
2024
Q3 | – | Sell |
-34,493
| Closed | -$561K | – | 1791 |
|
|
2024
Q2 | $561K | Buy |
+34,493
| New | +$561K | 0.03% | 764 |
|
|
2023
Q3 | – | Sell |
-52,744
| Closed | -$397K | – | 1583 |
|
|
2023
Q2 | $397K | Buy |
+52,744
| New | +$397K | 0.04% | 661 |
|
|
2023
Q1 | – | Sell |
-101,632
| Closed | -$927K | – | 1531 |
|
|
2022
Q4 | $927K | Buy |
+101,632
| New | +$927K | 0.14% | 217 |
|
|
2022
Q2 | – | Sell |
-145,411
| Closed | -$1.37M | – | 1186 |
|
|
2022
Q1 | $1.37M | Buy |
+145,411
| New | +$1.37M | 0.31% | 67 |
|
|
2021
Q4 | – | Sell |
-112,151
| Closed | -$1.09M | – | 876 |
|
|
2021
Q3 | $1.09M | Buy |
+112,151
| New | +$1.09M | 0.2% | 166 |
|
|
2021
Q2 | – | Sell |
-13,649
| Closed | -$155K | – | 895 |
|
|
2021
Q1 | $155K | Buy |
+13,649
| New | +$155K | 0.04% | 568 |
|